Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12006323 Ethynyl derivatives

Patent 12006323 was granted and assigned to Hoffmann-La Roche Limited on June, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Hoffmann-La Roche Limited

0

Current Assignee

Hoffmann-La Roche Limited

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Antonio Ricci0

Georg Jaeschke0

Lothar Lindemann0

Eric Vieira0

Daniel Rueher0

Wolfgang Guba0

Barbara Biemans0

Fionn O'Hara0

Date of Patent

June 11, 2024

0

Patent Application Number

173153490

Date Filed

May 9, 2021

0

Patent Citations

US Patent 11242349 Ethynyl derivatives

0

US Patent 10189848 Ethynyl derivatives

0

US Patent 7335356 Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein

0

US Patent 8513381 Melanocortin analogs with antimicrobial activity

0

US Patent 9695128 Ethynyl derivatives

0

US Patent 9725416 Ethynyl derivatives

0

US Patent 10065956 Ethynyl derivatives

0

Patent Primary Examiner

0

CPC Code

0

0

0

Patent abstract

The present invention relates to positive allosteric modulators (PAMs) of metabotropic glutamate receptor 4 (mGluR4) that may be used for the treatment of conditions such as Parkinson's disease, anxiety, emesis, obsessive compulsive disorder, autism, neuroprotection, cancer, depression and diabetes type 2.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12006323 Ethynyl derivatives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool